Early diagnosis of extranodal lymphoma in Sjögren's disease (SD) is crucial. Persistent salivary gland enlargement in SD patients warrants biopsy for early detection of MALT-lymphoma.
Area of Science:
Rheumatology
Oncology
Pathology
Context:
Sjögren's disease (SD) is an autoimmune disorder primarily affecting exocrine glands.
Patients with SD have an increased risk of developing lymphoproliferative disorders, particularly extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (MALT-lymphoma).
Early diagnosis of MALT-lymphoma in SD is challenging but essential for timely intervention and improved prognosis.
Purpose:
To develop an algorithm for the early diagnosis of extranodal MALT-lymphoma in patients with Sjögren's disease.
To identify key clinical and morphological features indicative of MALT-lymphoma development in SD patients.
To establish diagnostic criteria for MALT-lymphoma in the salivary and lacrimal glands of SD patients.
Summary:
A study of 457 Sjögren's disease patients identified 38 with lymphoproliferative diseases, including 15 with MALT-lymphoma.
MALT-lymphoma most frequently affected salivary glands (parotid, submandibular, minor) and lacrimal glands, predominantly at stages I-II.
Clinical indicators for MALT-lymphoma in SD include persistent salivary gland enlargement (>12 months), monoclonal immunoglobulins in serum, and light chains in urine.
Impact:
This research provides a framework for the early detection of MALT-lymphoma in Sjögren's disease patients.
Biopsy of enlarged parotid glands in SD patients is recommended for early diagnosis of malignant lymphoproliferation.
Improved diagnostic strategies can lead to earlier treatment initiation and potentially better outcomes for SD patients with MALT-lymphoma.